Results 261 to 270 of about 267,646 (342)
Neurobehavioral Assessment of Sensorimotor Function in Autism Using Smartphone Technology
ABSTRACT Differences in sensorimotor processing represent an important, yet underrecognized, feature of autism; typically assessed through subjective observations, which, although important, are susceptible to biases. To complement these observations, a more objective approach to assess sensorimotor function may be possible through reflex‐based ...
Kayleigh D. Gultig +19 more
wiley +1 more source
A sustainable business ecosystem: a case study demonstrating biochar's potential
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso +4 more
wiley +1 more source
Brand equity and willingness to pay for condoms in Zimbabwe. [PDF]
Evans WD +3 more
europepmc +1 more source
Abstract Fe‐, Co‐, and FeCo‐oxalates supported on silica gel (5 wt% metal load) were synthesized, characterized, and tested for the first time in solvent‐free furfural (FF) acetalization with C1–C8 alcohols at 70–170 °C under both conventional and microwave (MW)‐assisted conditions. The interaction of FF with linear C1–C4 alcohols yielded pincer‐shaped
Alexander Pokutsa +3 more
wiley +1 more source
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree +2 more
wiley +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source

